close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adagio Therapeutics, Inc. - Common Stock (NQ:ADGI)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.520 (1)
Ask (Size) 4.760 (2)
Prev. Close 4.640
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 109,755,624
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IVVD FINAL DEADLINE MONDAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
From The Rosen Law Firm PA
Via GlobeNewswire
INVIVYD SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. – IVVD, ADGI
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

More News

Read More
NATIONALLY RANKED ROSEN LAW FIRM Encourages Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – IVVD, ADGI
From Rosen Law Firm
Via Business Wire
Adagio Pauses FDA Emergency Use Request For Its COVID-19 Therapy
Via Benzinga
Invivyd Presented Joint Industry Rationale on Potential Expedited Development Pathways for Monoclonal Antibodies at FDA-EMA Workshop
From Invivyd
Via GlobeNewswire
Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer
From Invivyd
Via GlobeNewswire
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
Via Benzinga
Signify Health And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Mithril Capital’s Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for Support of Successful Proxy Campaign
From Mithril Capital Management LLC
Via Business Wire
30 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
58 Biggest Movers From Yesterday
Via Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
51 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Drops 100 Points; Adagio Therapeutics Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
S&P 500 Set to Snap 4-Day Win Streak Despite Jobs Data
Via Talk Markets
Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?
Via InvestorPlace
MRNA Stock: What’s Going on With Moderna This Week?
Via InvestorPlace
SPCE Stock: What’s Going on With Virgin Galactic This Week?
Via InvestorPlace
Mid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge
Via Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga

Frequently Asked Questions

Is Adagio Therapeutics, Inc. - Common Stock publicly traded?
Yes, Adagio Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Adagio Therapeutics, Inc. - Common Stock trade on?
Adagio Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Adagio Therapeutics, Inc. - Common Stock?
The ticker symbol for Adagio Therapeutics, Inc. - Common Stock is ADGI on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today